← Back to Clinical Trials
Recruiting NCT07655050

NCT07655050 Antibiotic Irrigation and Suction Ureteral Access Sheath in RIRS

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07655050
Status Recruiting
Phase
Sponsor Hitit University
Condition Kidney Calculi
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2026-06-15
Primary Completion 2027-02-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Standard Retrograde Intrarenal SurgeryGentamicin IrrigationSuction-Enabled Ureteral Access Sheath

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2026-06-15 with a primary completion date of 2027-02-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Retrograde intrarenal surgery (RIRS) is a widely used treatment for kidney stones; however, postoperative infectious complications remain a significant concern. This prospective randomized factorial trial aims to evaluate whether gentamicin-containing irrigation fluid and the use of a suction ureteral access sheath can reduce postoperative fever, systemic inflammatory response syndrome (SIRS), and sepsis after RIRS. The study will also investigate the independent and combined effects of these two interventions on infectious outcomes.

Eligibility Criteria

Inclusion Criteria: * Patients scheduled for retrograde intrarenal surgery (RIRS) due to kidney stones * Male and female patients aged 18 years or older * Patients who voluntarily sign the informed consent form * Patients with sterile urine culture or whose preoperative infection has been treated and urine culture has become sterile Exclusion Criteria: * Patients with active urinary tract infection before surgery * Patients with chronic kidney disease * Pregnant patients * Patients with allergy to aminoglycoside-group drugs used in the study protocol, specifically gentamicin * Cases in which the ureter cannot be accessed and the procedure is postponed by placing a double-J stent instead of performing dilation

Contact & Investigator

Central Contact

MUSTAFA SERDAR ÇAĞLAYAN

✉ serdar.09.09@hotmail.com

📞 +90 507 431 1951

Frequently Asked Questions

Who can join the NCT07655050 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Calculi. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07655050 currently recruiting?

Yes, NCT07655050 is actively recruiting participants. Contact the research team at serdar.09.09@hotmail.com for enrollment information.

Where is the NCT07655050 trial being conducted?

This trial is being conducted at Çorum, Turkey (Türkiye), Çorum, Turkey (Türkiye).

Who is sponsoring the NCT07655050 clinical trial?

NCT07655050 is sponsored by Hitit University. The trial plans to enroll 180 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology